Kestra Medical Technologies (KMTS) Income towards Parent Company (2024 - 2026)

Kestra Medical Technologies (KMTS) has 3 years of Income towards Parent Company data on file, last reported at -$34.2 million in Q1 2026.

• Income towards Parent Company for Q1 2026 came in at -$34.2 million, down 57.02% year-over-year; the trailing twelve-month figure through Jan 2026 was -$135.6 million (down 1310.86% YoY), and the FY2025 annual result was -$105.6 million, down 463.06% from the prior year.
• Income towards Parent Company eased to -$34.2 million in Q1 2026 per KMTS's latest filing, from -$32.8 million in the prior quarter.
• Over five years, Income towards Parent Company peaked at $53.1 million in Q2 2024 and troughed at -$42.8 million in Q2 2025.
• A 3-year average of -$18.5 million and a median of -$21.8 million in 2025 frame the typical range for Income towards Parent Company.
• On a YoY basis, Income towards Parent Company climbed as much as 0.65% in 2025 and fell as far as 180.71% in 2025.
• A 3-year view of Income towards Parent Company shows it stood at -$20.6 million in 2024, then tumbled by 58.99% to -$32.8 million in 2025, then retreated by 4.21% to -$34.2 million in 2026.
• Business Quant data shows KMTS's Income towards Parent Company at -$34.2 million in Q1 2026, -$32.8 million in Q4 2025, and -$25.8 million in Q3 2025.